- Home
- ADV vs ALMS Comparison
ADV vs ALMS Comparison
Compare ADV & ALMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADV
- ALMS
- Stock Information
- Founded
- ADV 1987
- ALMS 2021
- Country
- ADV United States
- ALMS United States
- Employees
- ADV N/A
- ALMS N/A
- Industry
- ADV Business Services
- ALMS
- Sector
- ADV Consumer Discretionary
- ALMS
- Exchange
- ADV Nasdaq
- ALMS NYSE
- Market Cap
- ADV 415.1M
- ALMS 402.6M
- IPO Year
- ADV N/A
- ALMS 2024
- Fundamental
- Price
- ADV $1.15
- ALMS $3.29
- Analyst Decision
- ADV Strong Buy
- ALMS Strong Buy
- Analyst Count
- ADV 1
- ALMS 7
- Target Price
- ADV $2.50
- ALMS $26.83
- AVG Volume (30 Days)
- ADV 633.6K
- ALMS 1.1M
- Earning Date
- ADV 05-12-2025
- ALMS 05-14-2025
- Dividend Yield
- ADV N/A
- ALMS N/A
- EPS Growth
- ADV N/A
- ALMS N/A
- EPS
- ADV N/A
- ALMS N/A
- Revenue
- ADV $3,526,704,000.00
- ALMS $17,389,000.00
- Revenue This Year
- ADV N/A
- ALMS N/A
- Revenue Next Year
- ADV N/A
- ALMS N/A
- P/E Ratio
- ADV N/A
- ALMS N/A
- Revenue Growth
- ADV N/A
- ALMS N/A
- 52 Week Low
- ADV $1.04
- ALMS $3.18
- 52 Week High
- ADV $4.16
- ALMS $13.53
- Technical
- Relative Strength Index (RSI)
- ADV 42.45
- ALMS N/A
- Support Level
- ADV $1.11
- ALMS N/A
- Resistance Level
- ADV $1.32
- ALMS N/A
- Average True Range (ATR)
- ADV 0.11
- ALMS 0.00
- MACD
- ADV 0.01
- ALMS 0.00
- Stochastic Oscillator
- ADV 33.33
- ALMS 0.00
About ADV Advantage Solutions Inc.
Advantage Solutions Inc is a omnichannel retail solutions agency in North America, uniquely positioned at the intersection of consumer-packaged goods (CPG) brands and retailers.
About ALMS ALUMIS INC
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.